The Effect of Vitamin A on Decreased β-hCG Production in Molar Pregnancy
Archives of Medical Laboratory Sciences,
Vol. 5 No. 3 (2019),
1 July 2019
,
Page 1-6
https://doi.org/10.22037/amls.v5i3.29185
Abstract
Background and Aim: Gestational trophoblastic disease (GTD) is defined as a group of disorders; they are characterized by uncontrolled trophoblastic cell proliferation and overproduction of β-HCG. It seems that an inappropriate diet is one of the major risk factors of GTD. Regardless of the size of the uterus; mole depletion by curettage suction is usually the preferred treatment. This study aimed to evaluate the effect of vitamin A and curettage suction on the faster reduction of β-hCG level, and faster recovery of disease, consequently. Materials and Methods: In this study case (n=26) and control (n=26) groups received 50,000 IU of vitamin A intramuscularly, before and after curettage. β-hCG was measured weekly and after reaching zero every month for six months. RIA was used for measurement. Results: Vitamin A reduced the level of β-hCG to zero in the patient compared to the control, one week earlier; this effect was statistically significant (P-Value <0.05). One of the members of the control group during follow-up progressed to gestational trophoblastic disease (GTN). There was no significant relationship between ABO blood groups among the two groups (P-Value: 0.9). There was no significant relationship between gravity, parity and hematology parameters between the two groups (P-Value >0.05). Conclusion: Finally, it can be said that vitamin A intake in patients with GTD, along with other therapies, can improve the speed of recovery; it can prevent the disease progression. However, it does not prevent progression to GTN, completely. Therefore, further studies are needed in future studies.
- Vitamin A
- Gestational Trophoblastic Disease
- β-HCG
- Hydatidiform Moles
How to Cite
References
Shaaban AM, Rezvani M, Haroun RR, Kennedy AM, Elsayes KM, Olpin JD, et al. Gestational trophoblastic disease: clinical and imaging features. Radiographics. 2017;37(2):681-700. https://doi.org/10.1148/rg.2017160140
Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan P, et al. Update on the diagnosis and management of gestational trophoblastic disease. International Journal of Gynecology & Obstetrics. 2015;131:S123-S6. https://doi.org/10.1016/j.ijgo.2015.06.008
Usui H, Qu J, Sato A, Pan Z, Mitsuhashi A, Matsui H, et al. Gestational Trophoblastic Neoplasia From Genetically Confirmed Hydatidiform Moles: Prospective Observational Cohort Study. International Journal of Gynecologic Cancer. 2018;28(9):1772-80. http://dx.doi.org/10.1097/IGC.0000000000001374
Verit FF. May platelet count be a predictor of low-risk persistent gestational trophoblastic disease? Archives of gynecology and obstetrics. 2011;283(4):695-9. https://doi.org/10.1007/s00404-010-1408-2
Lertkhachonsuk A, Hanvoravongchai P. Comparison of Cost-Effectiveness Between Actinomycin D Versus Methotrexate-Folinic Acid in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia. The Journal of reproductive medicine. 2016;61(5-6):230-4. https://europepmc.org/article/med/27424364
Kolusari A, Adali E, Kurdoglu M, Yildizhan R, Cebi A, Edirne T, et al. Catalase activity, serum trace element and heavy metal concentrations, vitamin A, vitamin D and vitamin E levels in hydatidiform mole-Serum levels of catalase, Zn, Co, and vitamin A, D, and E were significantly lower in patients with hydatiform mole compared with healthy pregnant women and non pregnant controls. Clinical & Experimental Obstetrics & Gynecology. 2009;36(2):102. https://doi.org/10.1177/147323000803600622
Andrijono A, Muhilal M. Prevention of post-mole malignant trophoblastic disease with vitamin A. Asian Pac J Cancer Prev. 2010;11(2):567-70. https://www.ncbi.nlm.nih.gov/pubmed/?term=Prevention+of+Post-
Sutanto EH, Winarno GN, Firmansah A. Effect of Methotrexate Combination with Vitamin A on Serum Levels of beta hCG in Low Risk of Gestational Trophoblastic Tumors Treatment. Indonesian Journal of Obstetrics and Gynecology. 2012;35(2):84-6. https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=Sutanto
Cunnigham F. leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. Williams Obstetrics. NewYork: McGraw Hill; 2005. https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q
Rajaei E, Shahbazian N, Rezaeeyan H, Mohammadi AK, Hesam S, Zayeri ZD. The effect of lupus disease on the pregnant women and embryos: a retrospective study from 2010 to 2014. Clinical rheumatology. 2019;38(11):3211-5. https://doi.org/10.1007/s10067-019-04682-3
Lawler S, Pickthall V, Fisher R, Povey S, Evans MW, Szulman A. Genetic studies of complete and partial hydatidiform moles. The Lancet. 1979;314(8142):580. DOI:10.1016/s0140-6736(79)91632-5
Feizollahi N, Zayeri ZD, Moradi N, Zargar M, Rezaeeyan H. The effect of coagulation factors polymorphisms on abortion. Frontiers in Biology. 2018;13(3):190-6. https://doi.org/10.1007/s11515-018-1500-8
Mazul AL, Weinberg CR, Engel SM, Siega-Riz AM, Zou F, Carrier KS, et al. Neuroblastoma in relation to joint effects of vitamin A and maternal and offspring variants in vitamin A-related genes: A report of the Children’s Oncology Group. Cancer epidemiology. 2019;61:165-71. https://doi.org/10.1016/j.canep.2019.06.009
Haybar H, Shahrabi S, Rezaeeyan H, Jodat H, Saki N. Strategies to inhibit arsenic trioxide‐induced cardiotoxicity in acute promyelocytic leukemia. Journal of cellular physiology. 2019;234(9):14500-6. https://doi.org/10.1002/jcp.28292
Oliveira S, Costa J, Faria I, Guerreiro SG, Fernandes R. Vitamin A Enhances Macrophages Activity Against B16-F10 Malignant Melanocytes: A New Player for Cancer Immunotherapy? medicina. 2019;55(9):604. https://doi.org/10.3390/medicina55090604
Tang X-H, Gudas LJ. Retinoids, retinoic acid receptors, and cancer. Annual Review of Pathology: Mechanisms of Disease. 2011;6:345-64. DOI:10.1146/annurev-pathol-011110-130303
Russo I, Caroppo F, Alaibac M. Vitamins and melanoma. Cancers. 2015;7(3):1371-87. https://doi.org/10.3390/cancers7030841
Kim J, Park MK, Li W-Q, Qureshi AA, Cho E. Association of Vitamin A Intake With Cutaneous Squamous Cell Carcinoma Risk in the United States. JAMA dermatology. 2019;155(11):1260-8. doi:10.1001/jamadermatol.2019.1937
Milani HS, Abdollahi M, Torbati S, Asbaghi T, Azargashb E. Risk Factors for Hydatidiform Mole: Is Husband’s Job a Major Risk Factor? Asian Pacific journal of cancer prevention: APJCP. 2017;18(10):2657. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747385/
Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-vand S, et al. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors. Fertility and sterility. 2015;104(3):649-54. https://doi.org/10.1016/j.fertnstert.2015.06.001
Eskicioglu¹ F, Ulkumen BA, Calik E. Complete blood count parameters may have a role in diagnosis of gestational trophoblastic disease. Pakistan journal of medical sciences. 2015;31(3):667. doi: http://dx.doi.org/10.12669/pjms.313.7109
- Abstract Viewed: 1174 times
- pdf Downloaded: 162 times